/images/ppid_59c68470-image-178334758886637520.webp)
/images/ppid_59c68470-image-178325002797514478.webp)
/images/ppid_59c68470-image-178308255119935457.webp)
What is the story about?
Torrent Pharmaceuticals has received approval from the National Company Law Tribunal (NCLT), Ahmedabad Bench, for the scheme of amalgamation of JB Chemicals & Pharmaceuticals Ltd. with the company and their respective shareholders.
In a regulatory filing dated July 6, 2026, Torrent Pharmaceuticals said the scheme of amalgamation has been sanctioned by the NCLT under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The tribunal passed its order on July 6, 2026.
The company said a copy of the order is available on the website of the Hon'ble NCLT.
Torrent Pharmaceuticals further said the scheme will become effective upon filing of the certified copy of the NCLT order with the Registrar of Companies (ROC). The company added that it will inform the stock exchanges of the effective date once the scheme comes into effect.
The amalgamation relates to JB Chemicals & Pharmaceuticals Ltd. as the transferor company and Torrent Pharmaceuticals Ltd. as the transferee company, along with their respective shareholders, as outlined in the sanctioned scheme.
Torrent Pharmaceuticals shares ended 1.04% higher at ₹4,818 on the NSE on Monday.
In a regulatory filing dated July 6, 2026, Torrent Pharmaceuticals said the scheme of amalgamation has been sanctioned by the NCLT under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The tribunal passed its order on July 6, 2026.
The company said a copy of the order is available on the website of the Hon'ble NCLT.
Torrent Pharmaceuticals further said the scheme will become effective upon filing of the certified copy of the NCLT order with the Registrar of Companies (ROC). The company added that it will inform the stock exchanges of the effective date once the scheme comes into effect.
The amalgamation relates to JB Chemicals & Pharmaceuticals Ltd. as the transferor company and Torrent Pharmaceuticals Ltd. as the transferee company, along with their respective shareholders, as outlined in the sanctioned scheme.
Torrent Pharmaceuticals shares ended 1.04% higher at ₹4,818 on the NSE on Monday.
/images/ppid_59c68470-image-17833450255206671.webp)
/images/ppid_59c68470-image-17832625238834831.webp)
/images/ppid_59c68470-image-178308506136288496.webp)
/images/ppid_59c68470-image-178308753343319641.webp)
/images/ppid_59c68470-image-178308505643838985.webp)
/images/ppid_59c68470-image-178309752412876709.webp)